Latest

Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

By Joe Petroziello — Pharmaceutical Executive

June 13, 2024

Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.

During BIO International Convention 2024, CEO Dave Bearss, PhD, of Halia Therapeutics, discussed the biopharmaceutical company’s progress in inflammation drug discovery. Founded in 2017, Halia Therapeutics supports the discovery and development of novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases.

https://www.pharmexec.com/view/pushing-boundaries-revolutionize-chronic-inflammation-therapy

In The News

Pushing Boundaries to Revolutionize Chronic Inflammation Therapy

By Joe Petroziello -- Pharmaceutical Executive June 13, 2024 Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions. During BIO International Convention 2024, CEO Dave Bearss, PhD, of Halia...

Utah Founder 100 Honorees Named

Venture Capital Podcast has released their Founder 100 honoree list for Utah. It is a crowd-nominated, peer-voted list of the state's top founders in terms of their attractiveness to investors. The honorees and a large group of investors will meet this evening in a...

Press Releases

Venture Capital Podcast Reveals Its Founder 100 for Utah

NEWS PROVIDED BY Venture Capital PodcastJun 13, 2024, 00:35 ET -- The 2024 list celebrates the top 100 founders driving innovation and growth in the Utah community -- LEHI, Utah, June 13, 2024 /PRNewswire/ -- Today, the Venture Capital Podcast...

Contact Us

Corporate Headquarters

3900 N. Traverse Mountain Blvd., Suite 100
Lehi, Utah 84043
United States

info@haliatx.com |  +1 (385) 355-4315